Skip to main content
Clinical Trials/NCT04522154
NCT04522154
Completed
Not Applicable

Transcatheter Tricuspid Valve Interventions and Right Ventricular Function: Evaluation with Magnetic Resonance Imaging

Heart and Diabetes Center North-Rhine Westfalia1 site in 1 country30 target enrollmentAugust 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tricuspid Valve Insufficiency
Sponsor
Heart and Diabetes Center North-Rhine Westfalia
Enrollment
30
Locations
1
Primary Endpoint
Influence of transcatheter tricuspid intervention on right ventricular basal diameter excursion in resonance tomography and echocardiography
Status
Completed
Last Updated
last year

Overview

Brief Summary

There is an urgent need for transcatheter tricuspid interventions, as pharmaceutical therapy becomes ineffective in advanced disease stages and surgery remains associated with high mortality rates. Despite the promising results, in some patients, although good procedural results were achieved, no clinical improvements were measured. Right ventricular dysfunction is suspected to be the cause of the failed therapeutic strategy. Therefore this study aims to analyze right ventricular function with magnet resonance imaging before and 3-months after the procedure in order to gain insight into the prevalence and dynamics of right ventricular dysfunction in severe tricuspid regurgitation and to identify possible predictors for treatment failure.

Registry
clinicaltrials.gov
Start Date
August 1, 2020
End Date
March 9, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Heart and Diabetes Center North-Rhine Westfalia
Responsible Party
Principal Investigator
Principal Investigator

Muhammed Gerçek

Principal Investigator

Heart and Diabetes Center North-Rhine Westfalia

Eligibility Criteria

Inclusion Criteria

  • Patients with severe tricuspid regurgitation undergoing transcatheter tricuspid intervention.

Exclusion Criteria

  • Patient with Incompatibility with magnetic resonance imaging or echocardiography
  • Another valve disorder that requires treatment
  • Severe precapillary pulmonary hypertension
  • Unstable angina or percutaneous coronary intervention within the last 30 days
  • Previous pacemaker/defibrillator implantation with intracardiac leads
  • Patients with cardiac cachexia or a life expectancy less then 12 months
  • Allergies to the material used.

Outcomes

Primary Outcomes

Influence of transcatheter tricuspid intervention on right ventricular basal diameter excursion in resonance tomography and echocardiography

Time Frame: 3 Month

Changes on right ventricular basal diameter in resonance tomography and echocardiography after transcatheter tricuspid intervention

Influence of transcatheter tricuspid intervention on right ventricular global longitudinal strain resonance tomography and echocardiography

Time Frame: 3 Month

Changes on right ventricular global longitudinal in resonance tomography and echocardiography after transcatheter tricuspid intervention

Influence of transcatheter tricuspid intervention on tricuspid regurgitant fraction resonance tomography and echocardiography

Time Frame: 3 Month

Changes on tricuspid regurgitant fraction in resonance tomography and echocardiography after transcatheter tricuspid intervention

Influence of transcatheter tricuspid intervention on tricuspid annular plane systolic excursion resonance tomography and echocardiography

Time Frame: 3 month

Changes on tricuspid annular plane systolic excursion in magnet resonance tomography and echocardiography after of transcatheter tricuspid intervention

Influence of transcatheter tricuspid intervention on right ventricular stroke volume resonance tomography and echocardiography

Time Frame: 3 Month

Changes on right ventricular stroke volume in resonance tomography and echocardiography after transcatheter tricuspid intervention

Influence of transcatheter tricuspid intervention on right ventricular fractional area change resonance tomography and echocardiography

Time Frame: 3 Month

Changes on right ventricular fractional area change in resonance tomography and echocardiography after transcatheter tricuspid intervention

Influence of transcatheter tricuspid intervention on right ventricular ejection fraction resonance tomography and echocardiography

Time Frame: 3 Month

Changes on right ventricular ejection fraction in resonance tomography and echocardiography after transcatheter tricuspid intervention

Secondary Outcomes

  • rehospitalization rate(3 month)
  • Exercise Testing with 6 min walking test(3 month)
  • Stroke(3 month)
  • Death due to cardiovascular complication(3 month)
  • Influence of transcatheter tricuspid intervention on the cardiopulmonary exercise capacity(3 month)

Study Sites (1)

Loading locations...

Similar Trials